NO138806C - Analogifremgangsmaate for fremstilling av neuroleptisk aktive 6-fluor-substituert tiaxanten-derivater - Google Patents

Analogifremgangsmaate for fremstilling av neuroleptisk aktive 6-fluor-substituert tiaxanten-derivater

Info

Publication number
NO138806C
NO138806C NO4693/73A NO469373A NO138806C NO 138806 C NO138806 C NO 138806C NO 4693/73 A NO4693/73 A NO 4693/73A NO 469373 A NO469373 A NO 469373A NO 138806 C NO138806 C NO 138806C
Authority
NO
Norway
Prior art keywords
thiaxantene
fluor
derivatives
substituted
preparing
Prior art date
Application number
NO4693/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO138806B (no
Inventor
Joern Lasse Martin Buus
Niels Lassen
Allan Johan Bigler
Original Assignee
Kefalas As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kefalas As filed Critical Kefalas As
Publication of NO138806B publication Critical patent/NO138806B/no
Publication of NO138806C publication Critical patent/NO138806C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02Seven-membered rings
    • C07D337/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/14[b,f]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO4693/73A 1972-12-08 1973-12-07 Analogifremgangsmaate for fremstilling av neuroleptisk aktive 6-fluor-substituert tiaxanten-derivater NO138806C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5691072A GB1453828A (en) 1972-12-08 1972-12-08 Fluoro-substituted thiaxanthene derivatives

Publications (2)

Publication Number Publication Date
NO138806B NO138806B (no) 1978-08-07
NO138806C true NO138806C (no) 1978-11-15

Family

ID=10477876

Family Applications (1)

Application Number Title Priority Date Filing Date
NO4693/73A NO138806C (no) 1972-12-08 1973-12-07 Analogifremgangsmaate for fremstilling av neuroleptisk aktive 6-fluor-substituert tiaxanten-derivater

Country Status (19)

Country Link
JP (1) JPS594436B2 (fr)
AR (2) AR202805A1 (fr)
AT (1) AT332395B (fr)
BE (1) BE808347A (fr)
CH (2) CH590272A5 (fr)
CS (1) CS176259B2 (fr)
DE (1) DE2359359C3 (fr)
DK (1) DK145576C (fr)
ES (2) ES421098A1 (fr)
FI (1) FI57410C (fr)
FR (1) FR2209573B1 (fr)
GB (1) GB1453828A (fr)
HU (1) HU167778B (fr)
IE (1) IE38554B1 (fr)
NL (1) NL7316035A (fr)
NO (1) NO138806C (fr)
PL (1) PL95266B1 (fr)
SE (1) SE400287B (fr)
ZA (1) ZA738990B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ189108A (en) * 1977-12-29 1982-02-23 Kefalas As 2-methylthio-6-fluoro-9-(1-methyl-4-piperidylidene)-thioxanthene and pharmaceutical compositions intermediate 2-methylthio-6-fluoro-9-(1-methyl-4-piperidyl)-thioxanthen-9-ol
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
GB8628903D0 (en) * 1986-12-03 1987-01-07 Lunbeck A S H Neuroleptic compounds
US6395752B1 (en) * 1999-03-04 2002-05-28 Pharmaquest Limited Method of treating depression using 1-threo-methylphenidate
US6127385A (en) * 1999-03-04 2000-10-03 Pharmaquest Limited Method of treating depression using l-threo-methylphenidate
WO2008080398A1 (fr) * 2007-01-05 2008-07-10 Bkg Pharma Aps Agents anti-infectieux tels que des dérivés de phénothiazine et de thioxanthène pour traiter les maladies infectieuses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE585338A (fr) * 1958-12-04
FR1463787A (fr) * 1963-10-14 1966-07-22 Pfizer & Co C Composés de phosphonium aminoalcoyl-trisubstitués, dérivés de tels composés, et procédés pour leur préparation

Also Published As

Publication number Publication date
AT332395B (de) 1976-09-27
FI57410C (fi) 1980-08-11
ZA738990B (en) 1974-11-27
AR202672A1 (es) 1975-06-30
ES421098A1 (es) 1976-08-01
FR2209573B1 (fr) 1977-12-09
DE2359359A1 (de) 1974-06-27
ES444294A1 (es) 1977-10-01
PL95266B1 (pl) 1977-10-31
DE2359359C3 (de) 1978-11-02
AR202805A1 (es) 1975-07-24
SE400287B (sv) 1978-03-20
FI57410B (fi) 1980-04-30
AU6296673A (en) 1975-05-29
IE38554B1 (en) 1978-04-12
HU167778B (fr) 1975-12-25
JPS4994691A (fr) 1974-09-09
FR2209573A1 (fr) 1974-07-05
DK145576C (da) 1983-06-13
BE808347A (fr) 1974-03-29
IE38554L (en) 1974-06-08
ATA1000373A (de) 1976-01-15
CH590272A5 (fr) 1977-07-29
GB1453828A (en) 1976-10-27
CS176259B2 (fr) 1977-06-30
NO138806B (no) 1978-08-07
DK145576B (da) 1982-12-13
DE2359359B2 (de) 1978-02-16
JPS594436B2 (ja) 1984-01-30
CH592085A5 (fr) 1977-10-14
NL7316035A (fr) 1974-06-11

Similar Documents

Publication Publication Date Title
SE395366B (sv) Forfarande for framstellning av porosa tabletter
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
SE390819B (sv) Analogiforfarande for framstellning av piperazinyl-propyl-1,2,4-triazolinderivat
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
SE417968B (sv) Forfarande for framstellning av penamderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
NO138628C (no) Analogifremgangsmaate for fremstilling av farmakodynamisk aktive, basisk substituerte indanderivater
NO139124C (no) Fremgangsmaate for fremstilling av estere
SE423092B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
FI55626C (fi) Anordning foer framstaellning av en behaollare
SE7611202L (sv) Forfarande for framstellning av pyrazolodiazepinforeningar
NO138806C (no) Analogifremgangsmaate for fremstilling av neuroleptisk aktive 6-fluor-substituert tiaxanten-derivater
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
SE397088B (sv) Forfarande for framstellning av nya 2-propanolderivat
PH9482A (en) 3-(4-methylpiperazin-1-yl)carbonyloxy-2-quinol-2-yl isoindolin-1-one derivatives
SE385581B (sv) Forfarande for framstellning av foretrade n-metylolkarbamidforeningar
SE402454B (sv) Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen
NO140185C (no) Fremgangsmaate til fremstilling av indolderivater
SE403112B (sv) Analogiforfarande for framstellning av skopolaminderivat
SE419441B (sv) Forfarande for framstellning av butyrofenonderivat
SE405855B (sv) Analogiforfarande for framstellning av piperidinderivat